Chaojun Qi
Impact in
- Nephrology top 1%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
-
- Cancer-related molecular mechanisms research
Papers in
- Nephrology 19
- Acute Kidney Injury Research 9
- Chronic Kidney Disease and Diabetes 7
- Renal Diseases and Glomerulopathies 7
- Dialysis and Renal Disease Management 4
-
- Heme Oxygenase-1 and Carbon Monoxide 2
- Co-authors
- Xinghua Shao (22 shared papers)Shan Mou (25 shared papers)Zhaohui Ni (29 shared papers)Qisheng Lin (8 shared papers)Jianxiao Shen (7 shared papers)Weijia Xu (3 shared papers)Haijiao Jin (7 shared papers)Minfang Zhang (7 shared papers)
- Journals
- PLoS ONE (3 papers)Renal Failure (2 papers)BMC Nephrology (2 papers)Frontiers in Immunology (2 papers)Journal of Translational Medicine (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Chaojun Qi
38 papers receiving 1.0k citations
Chaojun Qi's Hit Papers
Peers
Comparison fields: 5 of 74
- Nephrology 368
- Cancer Research 110
- Clinical Biochemistry 46
- Critical Care and Intensive Care Medicine 30
- Pulmonary and Respiratory Medicine 180
Countries citing papers authored by Chaojun Qi
This map shows the geographic impact of Chaojun Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaojun Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaojun Qi more than expected).
Fields of papers citing papers by Chaojun Qi
This network shows the impact of papers produced by Chaojun Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaojun Qi. The network helps show where Chaojun Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaojun Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 157 | |
| 2 | Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis Hit paper breakdown → | 2023 | 153 |
| 3 | 2019 | 97 | |
| 4 | 2019 | 95 | |
| 5 | 2016 | 73 | |
| 6 | 2015 | 58 | |
| 7 | 2022 | 46 | |
| 8 | 2018 | 31 | |
| 9 | 2014 | 31 | |
| 10 | 2021 | 25 | |
| 11 | 2018 | 23 | |
| 12 | 2016 | 21 | |
| 13 | 2024 | 19 | |
| 14 | 2016 | 16 | |
| 15 | 2014 | 16 | |
| 16 | 2024 | 15 | |
| 17 | 2017 | 15 | |
| 18 | 2019 | 13 | |
| 19 | 2021 | 13 | |
| 20 | 2014 | 13 |
About Chaojun Qi
Chaojun Qi is a scholar working on Nephrology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Rheumatology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (9 papers), Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (7 papers), Systemic Lupus Erythematosus Research (5 papers), Ferroptosis and cancer prognosis (4 papers), Dialysis and Renal Disease Management (4 papers), Biomarkers in Disease Mechanisms (3 papers) and Heme Oxygenase-1 and Carbon Monoxide (2 papers). The work is most often cited by research in Nephrology (368 citations), Cancer Research (110 citations), Clinical Biochemistry (46 citations), Critical Care and Intensive Care Medicine (30 citations) and Pulmonary and Respiratory Medicine (180 citations). Chaojun Qi has collaborated with scholars based in China and United States. Frequent co-authors include Xinghua Shao, Shan Mou, Zhaohui Ni, Qisheng Lin, Jianxiao Shen, Weijia Xu, Haijiao Jin, Minfang Zhang, Chunlin Wang and Jingkui Wu. Their work appears in journals such as PLoS ONE, Renal Failure, BMC Nephrology, Frontiers in Immunology and Journal of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.